PT Kalbe Farma Tbk (PTKFF)
0.0524
0.00 (0.00%)
USD |
OTCM |
Aug 26, 16:00
PT Kalbe Farma Shareholders Equity (Quarterly) : 1.361B for June 30, 2026
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 1.361B |
| March 31, 2026 | 1.430B |
| December 31, 2025 | 1.398B |
| September 30, 2025 | 1.379B |
| June 30, 2025 | 1.380B |
| March 31, 2025 | 1.420B |
| December 31, 2024 | 1.416B |
| September 30, 2024 | 1.465B |
| June 30, 2024 | 1.332B |
| March 31, 2024 | 1.412B |
| December 31, 2023 | 1.391B |
| September 30, 2023 | 1.338B |
| June 30, 2023 | 1.341B |
| March 31, 2023 | 1.414B |
| December 31, 2022 | 1.309B |
| September 30, 2022 | 1.279B |
| June 30, 2022 | 1.279B |
| March 31, 2022 | 1.409B |
| December 31, 2021 | 1.374B |
| September 30, 2021 | 1.297B |
| June 30, 2021 | 1.234B |
| March 31, 2021 | 1.261B |
| December 31, 2020 | 1.239B |
| September 30, 2020 | 1.146B |
| June 30, 2020 | 1.144B |
| Date | Value |
|---|---|
| March 31, 2020 | 1.008B |
| December 31, 2019 | 1.145B |
| September 30, 2019 | 1.079B |
| June 30, 2019 | 1.038B |
| March 31, 2019 | 1.069B |
| December 31, 2018 | 1.017B |
| September 30, 2018 | 935.06M |
| June 30, 2018 | 930.88M |
| March 31, 2018 | 1.008B |
| December 31, 2017 | 978.87M |
| September 30, 2017 | 940.39M |
| June 30, 2017 | 907.73M |
| March 31, 2017 | 937.96M |
| December 31, 2016 | 883.97M |
| September 30, 2016 | 865.71M |
| June 30, 2016 | 812.45M |
| March 31, 2016 | 831.13M |
| December 31, 2015 | 759.17M |
| September 30, 2015 | 684.78M |
| June 30, 2015 | 717.80M |
| March 31, 2015 | 759.17M |
| December 31, 2014 | 757.53M |
| September 30, 2014 | 722.39M |
| June 30, 2014 | 700.45M |
| March 31, 2014 | 756.01M |
Shareholders' Equity Definition
Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| AstraZeneca PLC | 47.33B |
| ANI Pharmaceuticals, Inc. | 597.21M |
| Corcept Therapeutics, Inc. | 705.78M |
| Veru, Inc. | 28.38M |
| Avadel Pharmaceuticals Plc | 98.22M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 1.850B |
| Total Liabilities (Quarterly) | 409.06M |
| Debt to Equity Ratio | 0.034 |
| Current Ratio | 3.153 |
| Net Debt Paydown Yield | -0.15% |